Loncar Cancer Immunotherapy ETF Forecast

Loncar Cancer Immunotherapy ETF upgraded from Hold/Accumulate to Buy Candidate after Friday trading session.
(Updated on May 03, 2024)

CNCR Signals & Forecast

The Loncar Cancer Immunotherapy ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the ETF has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $14.98 and $15.43. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 13.69%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. The ETF had a Golden Star Signal on Wednesday, May 31, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.

Support, Risk & Stop-loss for Loncar Cancer Immunotherapy ETF

Loncar Cancer Immunotherapy finds support from accumulated volume at $15.66 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This ETF has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the ETF moved $0.200 between high and low, or 1.27%. For the last week the ETF has had daily average volatility of 3.23%.

Our recommended stop-loss: $15.34 (-3.30%) (This ETF has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (CNCR) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Loncar Cancer Immunotherapy ETF to open at $15.82, and during the day (based on 14 day Average True Range), to move between $15.36 and $16.36, which gives a possible trading interval of +/-$0.504 (+/-3.18%) up or down from last closing price. If Loncar Cancer Immunotherapy ETF takes out the full calculated possible swing range there will be an estimated 6.36% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $15.66 (1.26%) than the resistance at $16.26 (2.52%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Loncar Cancer Immunotherapy ETF ETF A Buy?

Several short-term signals are positive, despite the ETF being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for ETF to perform well in the short-term. We have upgraded our analysis conclusion for this ETF since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 2.583 Buy Candidate Upgraded

Predicted Opening Price for Loncar Cancer Immunotherapy ETF of Monday, May 6, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.